Home › Urothelial (Transitional Cell) Carcinoma › California › Torrance
Urothelial (Transitional Cell) Carcinoma clinical trials in Torrance, CA
3 studies for Urothelial (Transitional Cell) Carcinoma are looking for participants at sites in and around Torrance (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
RecruitingPhase 1/2
- UCLA Hematology/Oncology - Torrance, Torrance
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
RecruitingPhase 3
- Hunt Cancer Institute, an Affiliate of Cedars-Sinai Cancer (TMPN), Torrance
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
RecruitingPhase 2
- UCLA Hematology/Oncology - Torrance, Torrance
- UCLA Torrance Lomita Specialty Care, Torrance
Urothelial (Transitional Cell) Carcinoma trials in other cities
- Nashville, TN23 studies
- New York City, NY22 studies
- Houston, TX19 studies
- Dallas, TX18 studies
- Edison, NJ18 studies
- Los Angeles, CA17 studies
- Queens, NY15 studies
- Chicago, IL14 studies
- Arlington, VA12 studies
- Boston, MA11 studies
- San Antonio, TX11 studies
- Austin, TX10 studies
Other studies in Torrance
- Non-Small Cell Lung Cancer11 studies
- Breast Cancer9 studies
- Overweight9 studies
- Obesity9 studies
- Lung Cancer7 studies
- Cardiovascular Disease7 studies
- Bladder Cancer7 studies
- Schizophrenia6 studies
- Heart Failure5 studies
- Atherosclerosis5 studies
- Metastatic Cancer4 studies
- Colorectal Cancer4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.